Pharmacokinetic Population Modeling of Nico- Tine Incorporating Cyp2a6 Genotypes following Different Routes of Administration

Abstract

PHARMACOKINETIC POPULATION MODELING OF NICOTINE INCORPORATING CYP2A6 GENOTYPES FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION. Y. Yoon, MD, PhD, D. Verotta, PhD, N. Benowitz, MD, University of California San Francisco, Inje University (Korea), San Francisco, CA. PURPOSE: We developed a comprehensive population pharmacokinetic (PK) model to quantify the… (More)

Topics

Cite this paper

@inproceedings{Yoon2005PharmacokineticPM, title={Pharmacokinetic Population Modeling of Nico- Tine Incorporating Cyp2a6 Genotypes following Different Routes of Administration}, author={Y. Yoon}, year={2005} }